From: CXCL1 is elevated in the urine of bladder cancer patients
Non-cancer (%) N = 43 | Cancer (%) N = 43 | |
---|---|---|
Median age (range, y) | 63 (34–81) | 67 (20–89) |
Male:female ratio | 36:7 | 36:7 |
Race | ||
White | 27 (63) | 41 (95) |
African American | 2 (5) | 1 (2) |
Other | 14 (33) | 1 (2) |
Tobacco use | 16 (37) | 32 (74) |
Suspicious/positive cytology | 0 (0) | 22 (51) |
Median follow-up (range, months) | 3.5 (1–49) | 6 (1–43) |
Clinical stage | ||
Tis | n/a | 0 (0) |
Ta | n/a | 14 (33) |
T1 | n/a | 11 (26) |
T2 | n/a | 16 (37) |
T3/4 | n/a | 2 (4) |
Grade | ||
Low | n/a | 31 (72) |
High | n/a | 12 (28) |